Verwendung von Bärentraubenblätter (Arctostaphylos uva ursi)-, Birkenblätter (Betula)-, Schachtelhalmkraut (Equisetum)- und Brennessel (Urtica)-Extrakten

The invention relates to the use of extracts of bearberry leaves (Arctostaphylos uva ursi), birch leaves (Betula), horsetail (Equisetum) and stinging nettle (Urtica), especially dry extracts from the fresh or dried plants, to produce medicaments for treating or preventing (protecting against) damage caused to organs and tissue by radiation (radioprevention, radioprotection), infection (infection prophylaxis) and chemical action (chemoprevention, chemoprotection), especially damage to the O-MALT system of the small bowel (inflammatory diseases, enteritis regionalis Crohn), the lungs (inflammation, disease), the bronchial tubes and the rhinopharynx (rhino-pharyngo-bronchitis, rhinitis, pharyngitis, sinusitis), the bone marrow (aplasia of the bone marrow), the thymus (dysfunction, aplasia or hypoplasia resulting from damage caused by medicaments or radiation), the liver (atrophy, necrosis), for treating/preventing hepatitis A, B and C, for damage to the pancreas, insufficiency of the exocrine, secretory functions of proteases, esterases, carbohydrases and nucleases and impairment of the carbohydrate metabolism (Langerhans' islands), damage to the kidneys (insufficiency), and generally immunosuppressed conditions, for cellular immunostimulation, for treating leucocytopenia, granulocytopenia, lymphoctopenia, thrombocytopenia, erythrocytopenia (infect anaemia, tumour anaemia i.a.), immunoglobulin deficiency conditions, and for conditions resulting from AIDS, tumours and diseases with a suppressed immune system. Die Erfindung betrifft die Verwendung von Bärentraubenblättern(Arcostaphylos uva ursi, AU)-, Birkenblätter(Betula, BP)-, Schachtelhalmkraut(Equisetum, EM)- und Brennessel(Urtica, UD)-Extrakten, insbesondere Trockenextrakten aus der frischen oder getrockneten Pflanze zur Herstellung von Arzneimitteln zur Behandlung oder Prävention (Protektion) von strahlen- (Radioprävention, -protektion), infektions- (Infentionsprophylaxe) und chemisch bedingten Organ- und Gewebeschädigungen (Chemoprävention, -protektion) insbesondere des O-MALT-Systems des Dünndarms (entzündliche Erkrankungen, Enteritis regionalis Crohn), der Lunge (Entzündung, Erkrankung), der Bronchien und des Nasen-Rachenraums (Rhino-Pharyngo-Bronchitis, Thinitis, Pharyngitis, Sinusitis), des Knochenmarks (Knochenmarkaplasie), des Thymus Udysfunktion, Aplasie oder Hypoplasie infolge medikamenten- oder strahlenbedingter Schädigung, der Leber (Athropie, Nekrose), Hepatitis A, B und C, der Bauchspeicheldr